{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:44:20Z","timestamp":1790837060123,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1957,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1111\/jth.13717","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T05:05:18Z","timestamp":1499058318000},"page":"1307-1316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Prothrombotic aspects of sickle cell disease"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-7847","authenticated-orcid":false,"given":"E.","family":"Sparkenbaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pawlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13717_bb0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13717_bb0015","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.1213775","article-title":"Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum\u2010infected erythrocytes","volume":"334","author":"Cyrklaff","year":"2011","journal-title":"Science"},{"key":"10.1111\/jth.13717_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model\u2010based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.13717_bb0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A\u00a0randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13717_bb0030","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2011-08-374447","article-title":"Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down\u2010modulating E\u2010selectin","volume":"119","author":"Lebensburger","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13717_bb0040","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.V98.6.1802","article-title":"Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase","volume":"98","author":"Wagener","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0045","doi-asserted-by":"crossref","first-page":"24430","DOI":"10.1074\/jbc.M703570200","article-title":"Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors","volume":"282","author":"Porto","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13717_bb0050","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0060","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.chest.2015.12.016","article-title":"Crises in sickle cell disease","volume":"149","author":"Novelli","year":"2016","journal-title":"Chest"},{"key":"10.1111\/jth.13717_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tracli.2008.04.001","article-title":"Mouse models of sickle cell disease","volume":"15","author":"Beuzard","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1111\/jth.13717_bb0070","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"Paszty","year":"1997","journal-title":"Science"},{"key":"10.1111\/jth.13717_bb0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0080","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia\u2010induced vasoocclusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/jth.13717_bb0085","doi-asserted-by":"crossref","first-page":"L705","DOI":"10.1152\/ajplung.00288.2002","article-title":"Hypoxia\u2010induced acute lung injury in murine models of sickle cell disease","volume":"286","author":"Pritchard","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1111\/jth.13717_bb0090","first-page":"297","article-title":"Hypoxia\/reoxygenation stress increases markers of vaso\u2010occlusive crisis in sickle SAD mice","volume":"54","author":"Aufradet","year":"2013","journal-title":"Clin Hemorheol Micro"},{"key":"10.1111\/jth.13717_bb0095","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase\u20101 is a modulator of inflammation and vaso\u2010occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1111\/jth.13717_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.20143","article-title":"Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy","volume":"77","author":"Kalambur","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13717_bb0105","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme\u2010induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0110","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nm.1939","article-title":"Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury","volume":"15","author":"Hidalgo","year":"2009","journal-title":"Nat Med"},{"key":"10.1111\/jth.13717_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/asheducation-2007.1.91","article-title":"Hypercoagulability in sickle cell disease: new approaches to an old problem","author":"Ataga","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.13717_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.thromres.2011.10.016","article-title":"Evaluation of the procoagulant activity of endogenous phospholipids in the platelet\u2010free plasma of children with sickle cell disease using functional assays","volume":"130","author":"Noubouossie","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13717_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.22206","article-title":"Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children","volume":"87","author":"Noubouossie","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13717_bb0130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/jth.13416","article-title":"Thrombin generation and cell\u2010dependent hypercoagulability in sickle cell disease","volume":"14","author":"Whelihan","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.V112.11.538.538","article-title":"The Protein C Pathway in Human and Murine Sickle Cell Disease: alterations in Protein C, Thrombomodulin (TM), and Endothelial Protein C Receptor (EPCR) at Baseline and during Acute Vaso\u2010Occlusion","volume":"112","author":"Guo","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"10.1111\/jth.13717_bb0150","first-page":"858","article-title":"Pulmonary changes in sickle cell disease","volume":"103","author":"Oppenheimer","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1111\/jth.13717_bb0155","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.13717_bb0160","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1540-8175.2010.01201.x","article-title":"Live\/Real time three\u2010dimensional transthoracic echocardiographic assessment of inferior vena cava and hepatic vein thrombosis in sickle cell disease","volume":"27","author":"Singh","year":"2010","journal-title":"Echocardiography"},{"key":"10.1111\/jth.13717_bb0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00464-002-4529-2","article-title":"Portal vein thrombosis following laparoscopic surgery in a patient with sickle cell disease","volume":"17","author":"Ng","year":"2003","journal-title":"Surg Endosc"},{"key":"10.1111\/jth.13717_bb0170","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood.V84.9.3189.3189","article-title":"Sickle cell disease of transgenic SAD mice","volume":"84","author":"Trudel","year":"1994","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0175","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-07-2135","article-title":"Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease\u2010specific lung injury induced by hypoxia\/reoxygenation","volume":"102","author":"de Franceschi","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2012.12.016","article-title":"Venous thromboembolism in adults with sickle cell disease: a serious and under\u2010recognized complication","volume":"126","author":"Naik","year":"2013","journal-title":"Am J Med"},{"key":"10.1111\/jth.13717_bb0185","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2012.04697.x","article-title":"Pulmonary embolism in sickle cell disease: a case\u2010control study","volume":"10","author":"Novelli","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0190","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jth.12744","article-title":"Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease","volume":"12","author":"Naik","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease\u2010associated pulmonary hypertension","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.13717_bb0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.96.09020356","article-title":"The role of thrombosis in severe pulmonary hypertension","volume":"9","author":"Chaouat","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1111\/jth.13717_bb0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1111\/jth.13717_bb0210","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.thromres.2010.01.042","article-title":"Cellular sources of tissue factor in endotoxemia and sepsis","volume":"125","author":"Pawlinski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13717_bb0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2141.2012.09065.x","article-title":"Tissue factor\u2010positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis","volume":"157","author":"Setty","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0220","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2014.114728","article-title":"Excess of heme induces tissue factor\u2010dependent activation of coagulation in mice","volume":"100","author":"Sparkenbaugh","year":"2015","journal-title":"Haematologica"},{"key":"10.1111\/jth.13717_bb0225","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1182\/blood-2010-08-301366","article-title":"Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin\u2010S","volume":"117","author":"Gavins","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V104.11.236.236","article-title":"Tissue factor deficiency decreases sickle cell\u2010induced vascular stasis in a hematopoietic stem cell transplant model of murine sickle cell disease","volume":"104","author":"Hillery","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0235","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1538-7836.2008.03177.x","article-title":"Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia","volume":"6","author":"Setty","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0240","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1172\/JCI1932","article-title":"Tissue factor expression by endothelial cells in sickle cell anemia","volume":"101","author":"Solovey","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13717_bb0245","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2003-10-3719","article-title":"Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia\/reoxygenation and inhibited by lovastatin","volume":"104","author":"Solovey","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trsl.2009.10.004","article-title":"Nuclear factor\u2010kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease","volume":"155","author":"Kollander","year":"2010","journal-title":"Transl Res"},{"key":"10.1111\/jth.13717_bb0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.21582","article-title":"Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in\u00a0vivo in the sickle transgenic mouse","volume":"85","author":"Solovey","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13717_bb0260","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1182\/blood-2009-02-204990","article-title":"The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice","volume":"115","author":"Hebbel","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0265","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood-2015-11-681114","article-title":"Thrombin\u2010independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease","volume":"127","author":"Sparkenbaugh","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00281-011-0289-1","article-title":"Protease\u2010activated receptor 2 signaling in inflammation","volume":"34","author":"Rothmeier","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1111\/jth.13717_bb0275","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0280","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2014-02-553081","article-title":"FXa takes center stage in vascular inflammation","volume":"123","author":"Ruf","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0285","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood.V91.11.4216","article-title":"Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease","volume":"91","author":"Key","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0290","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.2010.08480.x","article-title":"A pilot study of the short\u2010term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction","volume":"153","author":"Hoppe","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0295","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1538-7836.2012.04861.x","article-title":"Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia","volume":"10","author":"Colella","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0300","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood-2012-06-437772","article-title":"Tissue factor\u2010positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0305","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2015-01-625707","article-title":"Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice","volume":"126","author":"Arumugam","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease\u2010activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1111\/jth.13717_bb0315","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2004-02-0713","article-title":"The contribution of endothelial cell P\u2010selectin to the microvascular flow of mouse sickle erythrocytes in\u00a0vivo","volume":"104","author":"Embury","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0320","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2004-07-2698","article-title":"Differential regulation of endothelial exocytosis of P\u2010selectin and von Willebrand factor by protease\u2010activated receptors and cAMP","volume":"107","author":"Cleator","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso\u2010occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0330","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13717_bb0335","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1177\/153537020422901104","article-title":"Fibrin(ogen)\u2010alpha M beta 2 interactions regulate leukocyte function and innate immunity in\u00a0vivo","volume":"229","author":"Flick","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1111\/jth.13717_bb0340","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/ajh.20982","article-title":"Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice","volume":"82","author":"Roszell","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13717_bb0345","doi-asserted-by":"crossref","first-page":"71a\u2010a","DOI":"10.1182\/blood.V104.11.236.236","article-title":"Tissue factor deficiency decreases sickle cell\u2010induced vascular stasis in a hematopoietic stem cell transplant model of murine sickle cell disease","volume":"104","author":"Hillery","year":"2004","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-3848(01)00247-X","article-title":"Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in\u00a0vivo circulating thrombin","volume":"102","author":"Dupuy","year":"2001","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13717_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0306-9877(91)90029-X","article-title":"Large\u2010vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications","volume":"35","author":"Francis","year":"1991","journal-title":"Med Hypotheses"},{"key":"10.1111\/jth.13717_bb0360","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/jcp.33.7.622","article-title":"Platelet hyperactivity in sickle\u2010cell disease: a consequence of hyposplenism","volume":"33","author":"Kenny","year":"1980","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.13717_bb0365","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/jth.12422","article-title":"Mechanisms of hemolysis\u2010associated platelet activation","volume":"11","author":"Helms","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0370","doi-asserted-by":"crossref","first-page":"e0167899","DOI":"10.1371\/journal.pone.0167899","article-title":"HbS Binding to GP1balpha Activates Platelets in Sickle Cell Disease","volume":"11","author":"Annarapu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13717_bb0375","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"10.1111\/jth.13717_bb0380","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet\u2010mediated inflammation","volume":"26","author":"Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13717_bb0385","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","article-title":"P\u2010selectin\u2010mediated platelet\u2010neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease","volume":"30","author":"Polanowska\u2010Grabowska","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13717_bb0390","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P\u2010selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13717_bb0395","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2141.2010.08087.x","article-title":"Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3\u2010mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity","volume":"149","author":"Proenca\u2010Ferreira","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06740.x","article-title":"Beta\u2010thalassaemia and sickle cell anaemia as paradigms of hypercoagulability","volume":"139","author":"Ataga","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0405","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.thromres.2013.08.002","article-title":"A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease","volume":"132","author":"Desai","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13717_bb0410","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000206360","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"key":"10.1111\/jth.13717_bb0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"key":"10.1111\/jth.13717_bb0420","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1512021","article-title":"A Multinational trial of prasugrel for sickle cell vaso\u2010occlusive events","volume":"374","author":"Heeney","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13717_bb0425","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjh.14112","article-title":"Microparticles in sickle cell anaemia: promise and pitfalls","volume":"174","author":"Hebbel","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0430","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/295612a0","article-title":"Release of spectrin\u2010free spicules on reoxygenation of sickled erythrocytes","volume":"295","author":"Allan","year":"1982","journal-title":"Nature"},{"key":"10.1111\/jth.13717_bb0435","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","article-title":"Sickle blood contains tissue factor\u2010positive microparticles derived from endothelial cells and monocytes","volume":"102","author":"Shet","year":"2003","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0440","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","article-title":"Circulating erythrocyte\u2010derived microparticles are associated with coagulation activation in sickle cell disease","volume":"94","author":"van Beers","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/jth.13717_bb0445","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2012.068965","article-title":"Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe","volume":"98","author":"Nouraie","year":"2013","journal-title":"Haematologica"},{"key":"10.1111\/jth.13717_bb0450","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0455","doi-asserted-by":"crossref","first-page":"e87243","DOI":"10.1371\/journal.pone.0087243","article-title":"Plasma concentration of platelet\u2010derived microparticles is related to painful vaso\u2010occlusive phenotype severity in sickle cell anemia","volume":"9","author":"Nebor","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13717_bb0460","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet\u2010 and erythrocyte\u2010derived microparticles trigger thrombin generation via factor XIIa","volume":"10","author":"Van Der Meijden","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0465","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P\u2010selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0470","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11239-013-1028-3","article-title":"Clinical significance of circulating blood and endothelial cell microparticles in sickle\u2010cell disease","volume":"38","author":"Kasar","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13717_bb0475","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000362148","article-title":"Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia","volume":"133","author":"Brunetta","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1111\/jth.13717_bb0480","doi-asserted-by":"crossref","first-page":"e29786","DOI":"10.1371\/journal.pone.0029786","article-title":"Association of coagulation activation with clinical complications in sickle cell disease","volume":"7","author":"Ataga","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13717_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","article-title":"Factor XII as a therapeutic target in thromboembolic and inflammatory diseases","volume":"37","author":"Nickel","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13717_bb0490","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/jth.13717_bb0495","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12975-012-0186-5","article-title":"Inhibition of factor XII\u2010mediated activation of Factor XI provides protection against experimental acute ischemic stroke in mice","volume":"3","author":"Leung","year":"2012","journal-title":"Transl Stroke Res"},{"key":"10.1111\/jth.13717_bb0500","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2013-04-499111","article-title":"Factor XII inhibition reduces thrombus formation in a primate thrombosis model","volume":"123","author":"Matafonov","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0505","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa\u2010mediated factor XI activation in thrombus formation in\u00a0vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0510","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1405760","article-title":"Investigators F\u2010AT. Factor XI antisense oligonucleotide for prevention of venous thrombosis","volume":"372","author":"Buller","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13717_bb0515","first-page":"551","article-title":"Studies of the kallikrein\u2010kinin system in patients with sickle cell anemia","volume":"75","author":"Miller","year":"1983","journal-title":"J Natl Med Assoc"},{"key":"10.1111\/jth.13717_bb0520","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3476(85)80669-7","article-title":"Reduction of contact factors in sickle cell disease","volume":"106","author":"Gordon","year":"1985","journal-title":"J\u00a0Pediatr"},{"key":"10.1111\/jth.13717_bb0525","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V128.22.162.162","article-title":"FXIIa differentially regulates thrombin generation during steady state and vaso\u2010occlusive crisis in sickle cell mice","volume":"128","author":"Sparkenbaugh","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0530","doi-asserted-by":"crossref","first-page":"H652","DOI":"10.1152\/ajpheart.00825.2009","article-title":"Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF\u2010alpha and IL\u20101beta","volume":"298","author":"Khan","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/jth.13717_bb0535","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet\u2010dependent and platelet\u2010independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13717_bb0540","first-page":"3208","article-title":"Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation","volume":"118","author":"Maas","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13717_bb0545","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1182\/blood.V63.6.1453.1453","article-title":"In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E","volume":"63","author":"Hojima","year":"1984","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0550","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.immuni.2011.02.008","article-title":"Mast cells increase vascular permeability by heparin\u2010initiated bradykinin formation in\u00a0vivo","volume":"34","author":"Oschatz","year":"2011","journal-title":"Immunity"},{"key":"10.1111\/jth.13717_bb0555","first-page":"574","article-title":"Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises","volume":"66","author":"Chaplin","year":"1989","journal-title":"East Afr Med J"},{"key":"10.1111\/jth.13717_bb0560","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM196307252690403","article-title":"Long\u2010term anti\u2010coagulation in sickle\u2010cell disease. A clinical study","volume":"269","author":"Salvaggio","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13717_bb0565","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.1175","article-title":"Low adjusted\u2010dose acenocoumarol therapy in sickle cell disease: a pilot study","volume":"68","author":"Schnog","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13717_bb0570","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2141.1995.tb05607.x","article-title":"Low\u2010intensity oral anticoagulation in sickle\u2010cell disease reverses the prethrombotic state: promises for treatment?","volume":"90","author":"Wolters","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13717_bb0575","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2015.12.003","article-title":"Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies","volume":"30","author":"Noubouossie","year":"2016","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13717_bb0580","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1160\/Th06-12-0718","article-title":"Reduction of painful vaso\u2010occlusive crisis of sickle cell anaemia by tinzaparin in a double\u2010blind randomized trial","volume":"98","author":"Qari","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13717_bb0585","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood.V116.21.1635.1635","article-title":"Low molecular weight heparin reduces sVCAM\u20101 and lung congestion in a murine model of sickle cell disease","volume":"116","author":"Guo","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0590","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1060028016681129","article-title":"Outcomes of rivaroxaban use in patients with sickle cell disease","volume":"51","author":"Bhat","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jth.13717_bb0595","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene\u2010Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1111\/jth.13717_bb0600","doi-asserted-by":"crossref","first-page":"222ra17","DOI":"10.1126\/scitranslmed.3006804","article-title":"A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk","volume":"6","author":"Larsson","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.13717","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.13717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:19:53Z","timestamp":1761535193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622043070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1538783622043070"],"URL":"https:\/\/doi.org\/10.1111\/jth.13717","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic aspects of sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}